FOXM1 and neoplasm: FoxM1 has been implicated in cell cycle control [4–7], proliferation [8–11], DNA damage signaling [12, 13], invasion, angiogenesis, metastasis [11, 14–16], resistance to cancer drugs [13, 17–20], and aggressive tumor behavior and clinical outcomes [14–16, 21, 22].